Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/07/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 89 publications
Cholangiocarcinoma - Morphology, Immunohistochemistry, and Genetics.
Journal: Ceskoslovenska patologie
Published: October 16, 2025
Expanding Horizons in Cholangiocarcinoma: Emerging Targets Beyond FGFR2 and IDH1.
Journal: International journal of molecular sciences
Published: September 17, 2025
Lenvatinib after progression on pemigatinib and futibatinib in FGFR2 fusion-positive biliary tract cancer with an acquired kinase point mutation.
Journal: The oncologist
Published: August 18, 2025
Next-generation isoform-selective fibroblast growth factor receptor inhibitors.
Journal: Trends in pharmacological sciences
Published: August 14, 2025
The utility of green chemistry in spectrofluorometric quantification of Futibatinib; an oncological drug using fluorescamine and erythrosine B in pharmaceutical preparation and biological fluid.
Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
Published: August 07, 2025
Sequential Fibroblast Growth Factor Receptor Inhibition in Intrahepatic Cholangiocarcinoma: Navigating an Evolving Landscape of Resistance and Opportunity-A Case Report and Current Opinion.
Journal: Oncology and therapy
Published: June 16, 2025
Orally effective FDA-approved protein kinase targeted covalent inhibitors (TCIs): A 2025 update.
Journal: Pharmacological research
Published: May 27, 2025
Opportunities and Approaches to Optimising Advanced Cholangiocarcinoma Outcomes in the Era of Targeted Therapies: A Narrative Review.
Journal: Oncology and therapy
Published: May 23, 2025
Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trial.
Journal: The lancet. Gastroenterology & hepatology
Published: May 10, 2025
Pharmacologic features, clinical applications, and drug safety evaluation of futibatinib in the treatment of biliary tract cancer (BTC).
Journal: Expert opinion on drug safety
Published: May 01, 2025
A case of FGFR2 fusion-positive pancreatic head tumor with difficult differential diagnosis between cholangiocarcinoma and pancreatic ductal adenocarcinoma.
Journal: Clinical journal of gastroenterology
Published: April 08, 2025
Data mining and safety analysis of FGFR tyrosine kinase inhibitors based on the FAERS database.
Journal: Scientific reports
Published: March 11, 2025
Last Updated: 01/07/2026